TP53 and neoplasm: Increased NFκB activity has been reported in p53-null mice and loss of p53 was shown to trigger activation of NFκB in a mouse model of KrasG12D-driven lung adenocarcinoma while restoring p53 in p53-null lung tumors led to inhibition of NFκB and tumor suppression92,101.